Skip to main content

Advertisement

SpringerLink
Log in

Evaluation and management of adrenal neoplasms: endocrinologist and endocrine surgeon perspectives

  • Special Section: Adrenal Imaging
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

The evaluation and management of adrenal disease is a complex endeavor that relies on an expert knowledge of human physiology and anatomy. Careful and proper patient assessment mandates a balanced approach which marries the disciplines of endocrinology, surgery, and radiology. Any of these three specialties may be on the front line in performing the initial workup when an adrenal neoplasm is discovered. With an ever-increasing volume of cross-sectional imaging, be it CT, MRI, or PET, large numbers of adrenal incidentalomas are being discovered. A close collaboration amongst specialties should strive to streamline the initial evaluation and minimize unnecessary testing and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Young, W.F., Jr., Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am, 2000. 29(1): p. 159-85, x.

  2. Mansmann, G., et al., The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev, 2004. 25(2): p. 309-40.

  3. Bovio, S., et al., Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest, 2006. 29(4): p. 298-302.

  4. Barzon, L., et al., Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol, 2003. 149(4): p. 273-85.

  5. Fassnacht, M., et al., Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol, 2016. 175(2): p. G1-G34.

  6. Zeiger, M.A., et al., The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract, 2009. 15 Suppl 1: p. 1-20.

  7. Mayo-Smith, W.W., et al., Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol, 2017. 14(8): p. 1038-1044.

  8. Schteingart, D.E., et al., Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer, 2005. 12(3): p. 667-80.

  9. Ilias, I., et al., The optimal imaging of adrenal tumours: a comparison of different methods. Endocrine-Related Cancer, 2007. 14: p. 587-599.

  10. Blake, M., et al., Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology, 2006. 238: p. 578-585.

  11. Caoili, E., et al., Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology, 2002. 222: p. 629-633.

  12. Sahdev, A. and R. Reznek, Imaging evaluation of the non-functioning indeterminate adrenal mass. Trends in Endocrinology and Metabolism, 2004. 15: p. 271-276.

  13. Bharwani, N., et al., Adrenocortical carcinoma: the range of appearances on CT and MRI. American Journal of Roentgenology, 2011. 196: p. W706-W714.

  14. Young, W., Conventional imaging in adrenocortical carcinoma: update and perspectives. Hormones and Cancer, 2011. 2: p. 341-347.

  15. Vogel, W., et al., PET/CT: panacea, redundancy, or something in between? Journal of Nuclear Medicine, 2004. 45: p. 15S-24S.

  16. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements, 2002. 19(2): p. 1-25.

  17. Mantero, F., et al., A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab, 2000. 85(2): p. 637-44.

  18. Mazzaglia, P.J. and J.M. Monchik, Limited value of adrenal biopsy in the evaluation of adrenal neoplasm: a decade of experience. Arch Surg, 2009. 144(5): p. 465-70.

  19. Bancos, I., et al., The diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. European Journal of Endocrinology, 2016.

  20. Young, W., Clinical practice. The incidentally discovered adrenal mass. New England Journal of Medicine, 2007. 356: p. 601-610.

  21. Grumbach, M.M., et al., Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med, 2003. 138(5): p. 424-9.

  22. Berber, E. and A.E. Siperstein, Laparoscopic ultrasound. Surg Clin North Am, 2004. 84(4): p. 1061-84, vi.

  23. Siperstein, A.E., et al., Laparoscopic posterior adrenalectomy: technical considerations. Arch Surg, 2000. 135(8): p. 967-71.

  24. Harvey, A.M., Hyperaldosteronism: diagnosis, lateralization, and treatment. Surg Clin North Am, 2014. 94(3): p. 643-56.

  25. Young, W.F., et al., Role for adrenal venous sampling in primary aldosteronism. Surgery, 2004. 136(6): p. 1227-35.

  26. Song, J.H., F.S. Chaudhry, and W.W. Mayo-Smith, The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol, 2008. 190(5): p. 1163-8.

  27. Lorenz, K., et al., Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK). Langenbecks Arch Surg, 2019.

  28. Rossi, G.P., et al., An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension, 2014. 63(1): p. 151-60.

  29. Zarnegar, R., et al., The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg, 2008. 247(3): p. 511-8.

  30. Lenders, J.W., et al., Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2014. 99(6): p. 1915-42.

  31. Mazzaglia, P.J., Hereditary pheochromocytoma and paraganglioma. J Surg Oncol, 2012. 106(5): p. 580-5.

  32. Walz, M.K., et al., Posterior retroperitoneoscopic adrenalectomy–results of 560 procedures in 520 patients. Surgery, 2006. 140(6): p. 943-8; discussion 948-50.

  33. Alesina, P.F., et al., Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas. Langenbecks Arch Surg, 2012. 397(2): p. 233-8.

  34. Kuruba, R. and S.F. Gallagher, Current management of adrenal tumors. Curr Opin Oncol, 2008. 20(1): p. 34-46.

  35. Sturgeon, C. and E. Kebebew, Laparoscopic adrenalectomy for malignancy. Surg Clin North Am, 2004. 84(3): p. 755-74.

  36. Henry, J.F., et al., Complications of laparoscopic adrenalectomy: results of 169 consecutive procedures. World J Surg, 2000. 24(11): p. 1342-6.

  37. Carter, Y.M., et al., Safety and feasibility of laparoscopic resection for large (>/= 6 CM) pheochromocytomas without suspected malignancy. Endocr Pract, 2012. 18(5): p. 720-6.

  38. Mazzaglia, P.J. and M.P. Vezeridis, Laparoscopic adrenalectomy: balancing the operative indications with the technical advances. J Surg Oncol, 2010. 101(8): p. 739-44.

  39. Chen, Y., et al., Hypoglycemia after resection of pheochromocytoma. Surgery, 2014. 156(6): p. 1404-8; discussion 1408-9.

  40. Glazer, D.I. and W.W. Mayo-Smith, Management of incidental adrenal masses: an update. Abdom Radiol (NY), 2019.

  41. Margonis, G.A., et al., Outcomes after resection of cortisol-secreting adrenocortical carcinoma. Am J Surg, 2016. 211(6): p. 1106-13.

  42. Fassnacht, M. and B. Allolio, Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab, 2009. 23(2): p. 273-89.

  43. Wajchenberg, B.L., et al., Adrenocortical carcinoma: clinical and laboratory observations. Cancer, 2000. 88(4): p. 711-36.

  44. Bellantone, R., C.P. Lombardi, and M. Raffaelli, What is the appropriate role of minimally invasive vs. open surgery for small adrenocortical cancers? Curr Opin Oncol, 2015. 27(1): p. 44-9.

  45. Donatini, G., et al., Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach. Ann Surg Oncol, 2014. 21(1): p. 284-91.

  46. Miller, B.S., et al., Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbecks Arch Surg, 2010. 395(7): p. 955-61.

  47. Cooper, A.B., et al., Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc, 2013. 27(11): p. 4026-32.

  48. Miller, B.S., et al., Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg, 2010. 34(6): p. 1380-5.

  49. Dackiw, A.P., et al., Adrenal cortical carcinoma. World J Surg, 2001. 25(7): p. 914-26.

  50. Stefanidis, D., et al., SAGES guidelines for minimally invasive treatment of adrenal pathology. Surg Endosc, 2013. 27(11): p. 3960-80.

  51. Lenert, J.T., et al., Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery, 2001. 130(6): p. 1060-7.

  52. Bradley, C.T. and V.E. Strong, Surgical management of adrenal metastases. J Surg Oncol, 2014. 109(1): p. 31-5.

  53. Vazquez, B.J., et al., Adrenalectomy improves outcomes of selected patients with metastatic carcinoma. World J Surg, 2012. 36(6): p. 1400-5.

  54. Strong, V.E., et al., Laparoscopic adrenalectomy for isolated adrenal metastasis. Ann Surg Oncol, 2007. 14(12): p. 3392-400.

  55. Glenn, J.A., et al., Management of suspected adrenal metastases at 2 academic medical centers. Am J Surg, 2016. 211(4): p. 664-70.

  56. Kim, S.H., et al., The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer, 1998. 82(2): p. 389-94.

  57. Turrentine, F.E., et al., Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg, 2006. 203(6): p. 865-77.

  58. Novitsky, Y.W., D.E. Litwin, and M.P. Callery, The net immunologic advantage of laparoscopic surgery. Surg Endosc, 2004. 18(10): p. 1411-9.

  59. Gagner, M., A. Lacroix, and E. Bolte, Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med, 1992. 327(14): p. 1033.

  60. Chavez-Rodriguez, J. and J.L. Pasieka, Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series. Am J Surg, 2005. 189(5): p. 581-5; discussion 585-6.

  61. Saunders, B.D., et al., Trends in utilization of adrenalectomy in the United States: have indications changed? World J Surg, 2004. 28(11): p. 1169-75.

  62. Miccoli, P., et al., Adrenal surgery before and after the introduction of laparoscopic adrenalectomy. Br J Surg, 2002. 89(6): p. 779-82.

  63. Brunt, L.M., et al., Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg, 1996. 183(1): p. 1-10.

  64. Kebebew, E., A.E. Siperstein, and Q.Y. Duh, Laparoscopic adrenalectomy: the optimal surgical approach. J Laparoendosc Adv Surg Tech A, 2001. 11(6): p. 409-13.

  65. Assalia, A. and M. Gagner, Laparoscopic adrenalectomy. Br J Surg, 2004. 91(10): p. 1259-74.

  66. Shen, W.T., C. Sturgeon, and Q.Y. Duh, From incidentaloma to adrenocortical carcinoma: the surgical management of adrenal tumors. J Surg Oncol, 2005. 89(3): p. 186-92.

  67. Henneman, D., et al., Effect of laparoscopy on the indications for adrenalectomy. Arch Surg, 2009. 144(3): p. 255-9; discussion 259.

  68. Gallagher, S.F., et al., Trends in adrenalectomy rates, indications, and physician volume: A statewide analysis of 1816 adrenalectomies. Surgery, 2007. 142(6): p. 1011-21; discussion 1011-21.

  69. Berber, E., et al., Comparison of laparoscopic transabdominal lateral versus posterior retroperitoneal adrenalectomy. Surgery, 2009. 146(4): p. 621-5; discussion 625-6.

  70. Barczynski, M., A. Konturek, and W. Nowak, Randomized clinical trial of posterior retroperitoneoscopic adrenalectomy versus lateral transperitoneal laparoscopic adrenalectomy with a 5-year follow-up. Ann Surg, 2014. 260(5): p. 740-7; discussion 747-8.

  71. Lindeman, B., et al., Fifteen years of adrenalectomies: impact of specialty training and operative volume. Surgery, 2018. 163(1): p. 150-156.

  72. Economopoulos, K.P., et al., Laparoscopic versus robotic adrenalectomy: A comprehensive meta-analysis. Int J Surg, 2017. 38: p. 95-104.

Download references

Acknowledgements

Bryan Tutt in Scientific Publications provided editorial support.

Author information

Authors and Affiliations

  1. Warren Alpert School of Medicine at Brown University, 2 Dudley St., Providence, RI, 02905, USA

    Peter J. Mazzaglia

  2. Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Jeena Varghese & Mouhammed A. Habra

Authors
  1. Peter J. Mazzaglia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeena Varghese
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mouhammed A. Habra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter J. Mazzaglia.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mazzaglia, P.J., Varghese, J. & Habra, M.A. Evaluation and management of adrenal neoplasms: endocrinologist and endocrine surgeon perspectives. Abdom Radiol 45, 1001–1010 (2020). https://doi.org/10.1007/s00261-020-02464-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02464-z

Keywords

Search

Navigation